发明授权
US08632781B2 Immunogenic compounds comprising peptides of IL1β 失效
包含IL1beta肽的免疫原性化合物

Immunogenic compounds comprising peptides of IL1β
摘要:
The present invention relates to peptides derived from the proinflammatory cytokines, interleukin-1β (IL1β) and tumor necrosis factor α (TNFα), and their use in human or veterinary therapy, such as to generally treat diseases linked to the overproduction of IL1β or TNFα as well as acute or chronic inflammatory diseases, rheumatoid arthritis, septic shock, autoimmune diabetes, graft rejection in the host, etc.
信息查询
0/0